We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Microfluidic thrombosis analysis system: possibilities and limitations
Summary
This paper reviewed microfluidic thrombosis analysis systems, discussing their possibilities and limitations for studying clot formation dynamics under controlled flow conditions relevant to cardiovascular disease research.
Abstract Thrombosis is a double-edged sword. Normal thrombus formation within injured blood vessel is an important natural defensive mechanism to prevent excessive bleeding, whereas abnormal thrombus formation leads to critical disease such as stroke or myocardial infarction. One of keys in the pathophysiology mechanism involved in the thrombus formation is acute hemodynamic changes within the vessel lumen, which has been investigated mostly in pre-clinical and clinical studies. However, studies involving animal or human subjects are frequently limited by technical difficulties and requirement of substantial blood volume. Microfluidic systems have emerged as a valuable tool owing to their inherent advantages including minimal sample requirements and rapid analysis capabilities. In this mini review, we present a summary of microfluidic systems designed for thrombosis analysis, encompassing fabrication processes, design, and analysis methods. We also discuss both the potentials and limitations of microfluidic platform for the analysis of thrombus mechanisms.
Sign in to start a discussion.
More Papers Like This
Microfluidic-based in vitro thrombosis model for studying microplastics toxicity
Researchers developed a microfluidic-based thrombosis model to study how microplastics interact with the vascular system. Using both a mouse model and an on-chip system, the study found that microplastic exposure led to accumulation in the blood and decreased binding of fibrin to platelets, suggesting a potential risk of thrombus instability in blood flow.
Microplastic Effects on Thrombin–Fibrinogen Clotting Dynamics Measured via Turbidity and Thromboelastography
Researchers found that microplastics directly altered fibrin clot formation dynamics in a human thrombin-fibrinogen model, with effects varying by plastic type, size, and concentration, suggesting potential impacts on blood clotting and cardiovascular health.
Microfluidic Devices: A Tool for Nanoparticle Synthesis and Performance Evaluation
This review covers how tiny chip-like devices called microfluidic systems can be used to manufacture nanoparticles with precise control and then test their safety and effectiveness in realistic lab environments. While focused on medical nanoparticles, the technology is also relevant to studying how nanoplastics behave in biological systems.
Microplastic Effects on Thrombin-Fibrinogen Clotting Dynamics Measured via Turbidity
Researchers found that non-modified polystyrene microplastics significantly slowed fibrin clot formation in a laboratory model — reducing clotting rate up to 27-fold — while aminated polystyrene had minimal effect, suggesting microplastic surface chemistry may influence blood coagulation dynamics.
Exploring microplastic impact on whole blood clotting dynamics utilizing thromboelastography
Researchers used a blood clotting analysis technique to study how polystyrene microplastics of different sizes and surface types affect human blood clotting. They found that negatively charged particles consistently activated the clotting process, increasing both the speed and strength of clot formation in a size-dependent manner. The findings highlight that microplastic surface chemistry and particle size play important roles in how these particles might interact with blood.